Rimexolone

Rimexolone
Systematic (IUPAC) name
(8S,9S,10R,11S,13S,14S,16R,17S)-11-Hydroxy-10,13,16,17-tetramethyl-17-propanoyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
Clinical data
AHFS/Drugs.com monograph
MedlinePlus a606003
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
administration
ocular
Identifiers
CAS Number 49697-38-3 YesY
ATC code H02AB12 (WHO) S01BA13
PubChem CID 5311412
IUPHAR/BPS 7099
DrugBank DB00896 YesY
ChemSpider 4470902 N
UNII O7M2E4264D YesY
KEGG D05729 YesY
ChEMBL CHEMBL1200617 N
Chemical data
Formula C24H34O3
Molar mass 370.525 g/mol
 NYesY (what is this?)  (verify)

Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye.[1] It is marketed as a 1% eye drop suspension under the trade name Vexol by Alcon Laboratories.

References

  1. Kavuncu S, Horoz H, Ardagil A, Erbil HH (August 2008). "Rimexolone 1% versus prednisolone acetate in preventing early postoperative inflammation after cataract surgery". Int Ophthalmol 28 (4): 281–5. doi:10.1007/s10792-007-9131-0. PMID 17762913.



This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.